Axsome Therapeutics, Inc. · NASDAQ:AXSM

Axsome Therapeutics, Inc. insider trades

Axsome Therapeutics, Inc.'s insiders made 0 buys and 17 sales on the open market in the last 12 months. Each trade with the insider, role, price and filing.

Insider trades

InsiderTradeSharesPriceValueDate
Jacobson Mark L.
Officer: Chief Operating Officer
Sale10,000USD 208.65US$2.09MSep 3, 2026
Tabuteau Herriot
Director, Officer: Chief Executive Officer, 10% owner
Sale4,660USD 213.95US$997KAug 6, 2026
Tabuteau Herriot
Director, Officer: Chief Executive Officer, 10% owner
Sale45,004USD 212.01US$9.54MAug 5, 2026
Tabuteau Herriot
Director, Officer: Chief Executive Officer, 10% owner
Sale49,666USD 240.25US$11.9MJul 1, 2026
Jeffs Roger
Director
Sale286USD 249.12US$71,248Jun 11, 2026
Jeffs Roger
Director
Sale286USD 246.18US$70,407Jun 10, 2026
Coleman Mark
Director
Sale643USD 249.00US$160KJun 10, 2026
Mahony Susan
Director
Sale300USD 246.18US$73,854Jun 10, 2026
Mahony Susan
Director
Sale300USD 237.21US$71,163Jun 9, 2026
Pizzie Nick
Officer: Chief Financial Officer
Sale33,000USD 240.09US$7.92MJun 9, 2026
Tabuteau Herriot
Director, Officer: Chief Executive Officer, 10% owner
Sale49,670USD 241.01US$12MJun 9, 2026
Coleman Mark
Director
Sale5,537USD 223.39US$1.24MJun 2, 2026
Coleman Mark
Director
Sale6,000USD 230.30US$1.38MJun 1, 2026
Coleman Mark
Director
Sale6,000USD 233.46US$1.4MMay 29, 2026
Jacobson Mark L.
Officer: Chief Operating Officer
Sale233USD 228.18US$53,166May 5, 2026
Jacobson Mark L.
Officer: Chief Operating Officer
Sale4,517USD 227.94US$1.03MMay 4, 2026
Maizel Ari
Officer: Chief Commercial Officer
Sale7,500USD 182.42US$1.37MApr 22, 2026

Axsome Therapeutics, Inc. shareholders